MUTATIONS OF THE BCR-ABL- KINASE DOMAIN EXPLAIN THE IMATINIB FAILURE ONLY IN A MINORITY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

被引：0
|
作者：
Jardan, D. [1 ]
Talmaci, R. [1 ]
Coriu, D. [2 ]
Dragomir, M. [2 ]
Ursuleac, I. [1 ]
机构：
[1] Univ Med & Pharm Carol Davila, Bucharest, Romania
[2] Fundeni Clin Inst, Bucharest, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1333
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [41] Impact of BCR-ABL mutations on patients with chronic myeloid leukemia
    Hochhaus, Andreas
    La Rosee, Paul
    Mueller, Martin C.
    Ernst, Thomas
    Cross, Nicholas C. P.
    CELL CYCLE, 2011, 10 (02) : 250 - 260
  • [42] Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions
    Markose, Preetha
    Chendamarai, Ezhilarasi
    Balasubramanian, Poonkuzhali
    Velayudhan, Shaji Ramachandran
    Srivastava, Vivi M.
    Mathews, Vikram
    George, Biju
    Viswabandya, Auro
    Srivastava, Alok
    Chandy, Mammen
    LEUKEMIA & LYMPHOMA, 2009, 50 (12) : 2092 - 2095
  • [43] Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia
    Mario Tiribelli
    Roberto Latagliata
    Luigiana Luciano
    Fausto Castagnetti
    Antonella Gozzini
    Giovanna Rege Cambrin
    Mario Annunziata
    Fabio Stagno
    Patrizia Pregno
    Francesco Albano
    Elisabetta Abruzzese
    Pellegrino Musto
    Enrico Montefusco
    Carmen Fava
    Renato Fanin
    Fabrizio Pane
    Gianantonio Rosti
    Massimo Breccia
    Giuliana Alimena
    Paolo Vigneri
    Annals of Hematology, 2013, 92 : 179 - 183
  • [44] Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia
    Tiribelli, Mario
    Latagliata, Roberto
    Luciano, Luigiana
    Castagnetti, Fausto
    Gozzini, Antonella
    Cambrin, Giovanna Rege
    Annunziata, Mario
    Stagno, Fabio
    Pregno, Patrizia
    Albano, Francesco
    Abruzzese, Elisabetta
    Musto, Pellegrino
    Montefusco, Enrico
    Fava, Carmen
    Fanin, Renato
    Pane, Fabrizio
    Rosti, Gianantonio
    Breccia, Massimo
    Alimena, Giuliana
    Vigneri, Paolo
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 179 - 183
  • [45] ABL Kinase Domain Mutation in Chronic Myeloid Leukemia - Compliance to Imatinib Matters
    Jayachandran, P. K.
    Ganesan, Trivadi S.
    Mehra, Nikita
    Kannan, Krishnarathinam
    Dhanushkodi, Manikandan
    Radhakrishnan, Venkatraman
    Rajan, Arun Kumar
    Girishchandra, Joshi Archit
    Selvarajan, Gangothri
    Karunakaran, Parathan
    Sagar, Tenali Gnana
    BLOOD, 2019, 134
  • [46] In early-chronic phase chronic myeloid leukemia patients treated with imatinib, resistance is rarely mediated by Abl kinase domain mutations
    Soverini, Simona
    Gnani, Alessandra
    Colarossi, Sabrina
    Castagnetti, Fausto
    Abruzzese, Efisabetta
    Merante, Serena
    Breccia, Massimo
    Capucci, Adele
    Specchia, Giorgina
    Radaelli, Franca
    Palandri, Francesca
    Poerio, Angela
    Iacobucci, Ilaria
    Amabile, Marilina
    Rosti, Gianantonio
    Baccarani, Michele
    Martinelli, Giovanni
    BLOOD, 2007, 110 (11) : 574A - 574A
  • [47] Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib
    Golale Rostami
    Mohammad Hamid
    Majid Yaran
    Mohsen Khani
    Morteza Karimipoor
    Journal of Human Genetics, 2015, 60 : 253 - 258
  • [48] Impact of ABL kinase domain mutations on the outcome of patients with chronic myeloid leukemia (CML)
    Sweet, Kendra Lynn
    Komrokji, Rami S.
    Al Ali, Najla
    Crescentini, Robert M.
    Domingo, Gelenis
    Chavez, Julio C.
    Dalia, Samir
    Tinsley, Sara
    Lancet, Jeffery
    Zhang, Ling
    Pinilla-Ibarz, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] BCR-ABL TYROSINE KINASE DOMAIN MUTATIONS COMBINATIONS AFFECTS IMATINIB RESISTENCE IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
    Bintoro, S. U. Y.
    Amrita, P. N. A.
    Joewarini, E.
    Suryohusodo, P.
    Soebandiri, S.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (04): : 53 - 58
  • [50] IMPACT OF BCR-ABL MUTATIONS ON RESPONSE TO DASATINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB
    Tiribelli, M.
    Latagliata, R.
    Breccia, M.
    Luciano, L.
    Castagnetti, F.
    Gozzini, A.
    Cambrin, G. Rege
    Annunziata, M.
    Stagno, F.
    Pregno, P.
    Albano, F.
    Abruzzese, F.
    Musto, P.
    Sora, F.
    Ferrero, D.
    Montefusco, E.
    Cavazzini, F.
    Binotto, G.
    Fanin, R.
    Pane, F.
    Rosti, G.
    Santini, V.
    Fava, C.
    Alimena, G.
    Vigneri, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 347 - 347
12345